scispace - formally typeset
E

Effrosyni D. Manali

Researcher at National and Kapodistrian University of Athens

Publications -  108
Citations -  2190

Effrosyni D. Manali is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Idiopathic pulmonary fibrosis & Medicine. The author has an hindex of 23, co-authored 89 publications receiving 1647 citations. Previous affiliations of Effrosyni D. Manali include Cleveland Clinic & Paris Diderot University.

Papers
More filters
Journal ArticleDOI

MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.

TL;DR: It is found that the MUC5B promoter variant was associated with rheumatoid arthritis and more specifically associated with evidence of usual interstitial pneumonia on imaging and associated with an increased risk of ILD among patients with RA.
Journal ArticleDOI

Amiodarone: review of pulmonary effects and toxicity.

TL;DR: The development of lung complications appears to be associated with older age, duration of treatment and cumulative dosage, high levels of its desethyl metabolite, history of cardiothoracic surgery and/or use of high oxygen mixtures, use of iodinated contrast media and probably pre-existing lung disease as well as co-existing respiratory infections.
Journal ArticleDOI

Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis.

TL;DR: Evidence is provided that intermittent sleep oxygen desaturation significantly exceeds that of maximal exercise and is associated with survival in IPF patients, and this work implies the existence of a link between lung damage and apnea events resulting to the induction and severity of intermittent sleep breathing disorders that aggravate pulmonary arterial hypertension and influence IPF survival.
Journal ArticleDOI

High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations.

TL;DR: Assessment of pro‐inflammatory and pro‐fibrotic cytokines in the peripheral blood from stable and exacerbated IPF patients found high levels of IL‐6 and IL‐8 characterize early‐on IPF‐AEs and an increase in the levels ofIL‐ 6 andIL‐8 associates with worse outcome in all patients.
Journal ArticleDOI

Depression, physical activity, energy consumption, and quality of life in OSA patients before and after CPAP treatment

TL;DR: CPAP therapy improves QoL and lessens depressive symptoms in the authors' group of well-treated OSA patients, however, physical activity and energy expenditure did not present statistically significant improvement in the same group of Osa patients.